-
Novel Fumarate Esters as Neuroprotective Agents in Parkinson’s Disease
… immuno-modulatory and neuroprotective effects in cell-based systems, pre-clinical models of disease and clinical trials in multiple sclerosis and psoriasis patients. The biological …
-
North Shore LIJ: Brain Abnormalities in Parkinson's Patients Develop Before Symptoms Occur
January 20, 2010
… damaged in Parkinson's disease have new evidence that these systems become abnormal a few years before symptoms appear. … with a unique opportunity to study the brain scans at multiple times and compare the symptoms to changes in the …
-
Jian Peng, PhD
… framework for simultaneous dimensionality reduction of multiple heterogeneous biological networks. The latter … alpha-synuclein genetic network. Dr. Peng has received multiple awards in the field of computational biology, …
-
Farren Basil Shaw Briggs, PhD
… in genetic epidemiology. Dr. Briggs is a former National Multiple Sclerosis Society postdoctoral fellow. His research has focused on multiple sclerosis (MS), another complex neurodegenerative …
-
Paul Davies, PhD
… more recently motor neuron disease. He is also involved in multiple technology development projects in the areas of … ongoing in the Unit. Dr. Davies’ team also works on multiple industry projects and technology development. …
-
Aaron Sylvan Lord, MD, MSc
… and who are not English speakers. He also serves as a multiple principal investigator (PI) for The New York City … (NYCC-RCC) of NIH/NINDS StrokeNet and is a site PI for multiple StrokeNet and other neurology trials. To highlight …